Y-Intercept (HK)’s Sage Therapeutics SAGE Stock Holding History

Y-Intercept (HK)’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-303,888	Closed	-$2.77M	–	1978
2025 Q2	$2.77M	Buy	+303,888	New	+$2.24M	0.07%	459
2024 Q3	–	Sell	-22,094	Closed	-$240K	–	1744
2024 Q2	$240K	Buy	+22,094	New	+$283K	0.01%	1107
2023 Q3	–	Sell	-8,774	Closed	-$413K	–	1522
2023 Q2	$413K	Buy	+8,774	New	+$437K	0.04%	638
2023 Q1	–	Sell	-8,050	Closed	-$307K	–	1494
2022 Q4	$307K	Buy	+8,050	New	+$307K	0.05%	647
2022 Q2	–	Sell	-9,265	Closed	-$307K	–	1151
2022 Q1	$307K	Buy	+9,265	New	+$348K	0.07%	437
2021 Q1	–	Sell	-8,855	Closed	-$785K	–	777
2020 Q4	$785K	Buy	+8,855	New	+$653K	0.33%	70

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Y-Intercept (HK)'s SAGE Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 303,888 shares — an estimated $2.77M sold.

Y-Intercept (HK) first reported a position in SAGE in Q4 2020 and held it in 6 quarters. The position peaked at $2.77M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Y-Intercept (HK) reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 303,888 Sage Therapeutics shares in Q3 2025, an estimated $2.77M.
Y-Intercept (HK) first reported a position in Sage Therapeutics in Q4 2020 and held it in 6 quarters.
Y-Intercept (HK)'s Sage Therapeutics position peaked at $2.77M in Q2 2025.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.